{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:57:13Z","timestamp":1788541033735,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Liangshan Science and Technology Bureau","award":["No. 21ZDY0058"],"award-info":[{"award-number":["No. 21ZDY0058"]}]},{"name":"Liangshan Science and Technology Bureau","award":["No. 21ZDY0069"],"award-info":[{"award-number":["No. 21ZDY0069"]}]},{"name":"Sichuan Provincial Cadre Health Research Project","award":["No. 2021-230"],"award-info":[{"award-number":["No. 2021-230"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tuberculosis (TB) has a high morbidity and mortality rate, and its prevention and treatment focus is on impoverished areas. The Liangshan Yi Autonomous Prefecture is a typical impoverished area in western China with insufficient medical resources and high HIV positivity. However, there have been few reports of TB and drug resistance in this area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We collected the demographic and clinical data of inpatients with sputum smear positive TB between 2015 and 2021 in an infectious disease hospital in the Liangshan Yi Autonomous Prefecture. Descriptive analyses were used for the epidemiological data. The chi-square test was used to compare categorical variables between the drug-resistant and drug-susceptible groups, and binary logistic regression was used to analyse meaningful variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 2263 patients, 79.9% of whom were Yi patients. The proportions of HIV (14.4%) and smoking (37.3%) were higher than previously reported. The incidence of extrapulmonary TB (28.5%) was high, and the infection site was different from that reported previously. When drug resistance gene detection was introduced, the proportion of drug-resistant patients became 10.9%. Patients aged 15\u201344 years (OR 1.817; 95% CI 1.162\u20132.840; P\u2009&lt;\u20090.01) and 45\u201359 years (OR 2.175; 95% CI 1.335\u20133.543; P\u2009&lt;\u20090.01) had significantly higher incidences of drug resistance than children and the elderly. Patients with a cough of \u2265\u20092 weeks had a significantly higher chance of drug resistance than those with &lt;\u20092 weeks or no cough symptoms (OR 2.069; 95% CI 1.234\u20133.469; P\u2009&lt;\u20090.01). Alcoholism (OR 1.741; 95% CI 1.107\u20132.736; P\u2009&lt;\u20090.05) and high bacterial counts on sputum acid-fast smears (OR 1.846; 95% CI 1.115\u20133.058; P\u2009&lt;\u20090.05) were significant in the univariate analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sputum smear-positive TB predominated in Yi men (15\u201344 years) with high smoking, alcoholism, and HIV rates. Extrapulmonary TB, especially abdominal TB, prevailed. Recent drug resistance testing revealed higher rates in 15\u201359 age group and \u2265\u20092 weeks cough duration. Alcohol abuse and high sputum AFB counts correlated with drug resistance. Strengthen screening and supervision to curb TB transmission and drug-resistant cases in the region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08568-3","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T08:01:27Z","timestamp":1693987287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comorbidity and drug resistance of smear-positive pulmonary tuberculosis patients in the yi autonomous prefecture of China: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,6]]},"reference":[{"key":"8568_CR1","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis Nat Rev Dis Primers. 2016;2:16076.","journal-title":"Tuberculosis Nat Rev Dis Primers"},{"issue":"10181","key":"8568_CR2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin J, Cox H, Pai M, Tuberculosis. The Lancet. 2019;393(10181):1642\u201356.","journal-title":"The Lancet"},{"key":"8568_CR3","unstructured":"Global Tuberculosis Report. 2021. World Health Organization; Geneva: World Health Organizationaccessed 21 January 2022."},{"issue":"4","key":"8568_CR4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-2600(18)30057-2","volume":"6","author":"K Floyd","year":"2018","unstructured":"Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the end TB era. The Lancet Respiratory Medicine. 2018;6(4):299\u2013314.","journal-title":"The Lancet Respiratory Medicine"},{"issue":"12","key":"8568_CR5","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.1016\/S2468-2667(21)00203-6","volume":"6","author":"Q Long","year":"2021","unstructured":"Long Q, Guo L, Jiang W, Huan S, Tang S. Ending tuberculosis in China: health system challenges. The Lancet Public Health. 2021;6(12):e948\u2013e53.","journal-title":"The Lancet Public Health"},{"key":"8568_CR6","doi-asserted-by":"crossref","unstructured":"Rai B, Dixit K, Aryal TP, Mishra G, Siqueira-Filha NT, Paudel PR et al. Developing feasible, locally appropriate socioeconomic support for TB-Affected Households in Nepal. Trop Med Infect Dis. 2020;5(2).","DOI":"10.3390\/tropicalmed5020098"},{"key":"8568_CR7","unstructured":"Global Tuberculosis Report. 2020. Geneva: World Health Organization.: Published 2020. Accessed October 20, 2020. ; 2020."},{"issue":"1","key":"8568_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40249-021-00809-4","volume":"10","author":"Q Long","year":"2021","unstructured":"Long Q, Jiang WX, Zhang H, Cheng J, Tang SL, Wang WB. Multi-source financing for tuberculosis treatment in China: key issues and challenges. Infect Dis Poverty. 2021;10(1):17.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"8568_CR9","doi-asserted-by":"crossref","first-page":"16327","DOI":"10.1038\/s41598-021-95883-x","volume":"11","author":"J Cheng","year":"2021","unstructured":"Cheng J, Song B, Fu J, Zheng X, He T, Fu J. Genetic polymorphism of 19 autosomal STR loci in the Yi ethnic minority of Liangshan Yi autonomous prefecture from Sichuan province in China. Sci Rep. 2021;11(1):16327.","journal-title":"Sci Rep"},{"issue":"5","key":"8568_CR10","first-page":"467","volume":"24","author":"G Shan","year":"2011","unstructured":"Shan G, Wei D, Wang C, Zhang J, Wang B, Ma M, et al. Trends of overweight and obesity in Yi people between 1996 and 2007: an Yi migrant study. Biomed Environ Sci. 2011;24(5):467\u201374.","journal-title":"Biomed Environ Sci"},{"issue":"1","key":"8568_CR11","first-page":"53","volume":"25","author":"G Shan","year":"2012","unstructured":"Shan G, Wei D, Wang C, Zhang J, Wang B, Ma M, et al. Body Mass Index and Hypertension hemodynamic subtypes in Yi Farmers and Migrants. Biomed Environ Sci. 2012;25(1):53\u201360.","journal-title":"Biomed Environ Sci"},{"issue":"1","key":"8568_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s40249-020-00706-2","volume":"9","author":"RJ Liao","year":"2020","unstructured":"Liao RJ, Ji-Ke CN, Zhang T, Liao Q, Li L, Zhu TY, et al. Coronavirus disease 2019 epidemic in impoverished area: Liangshan Yi autonomous prefecture as an example. Infect Dis Poverty. 2020;9(1):112.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"8568_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12889-022-12504-6","volume":"22","author":"R Liao","year":"2022","unstructured":"Liao R, Hu L, Liao Q, Zhu T, Yang H, Zhang T. Analysis of death causes of residents in poverty-stricken Areas in 2020: take Liangshan Yi Autonomous Prefecture in China as an example. BMC Public Health. 2022;22(1):89.","journal-title":"BMC Public Health"},{"issue":"2","key":"8568_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JNC.0000000000000119","volume":"31","author":"H Yang","year":"2020","unstructured":"Yang H, Xie X, Nie A, Yin Y, Wang H, Chen H. HIV-Related Stigma among People living with HIV in Liangshan Yi Autonomous Prefecture, China. J Assoc Nurses AIDS Care. 2020;31(2):199\u2013207.","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"1","key":"8568_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00408-012-9440-6","volume":"191","author":"C Naing","year":"2013","unstructured":"Naing C, Mak JW, Maung M, Wong SF, Kassim AI. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung. 2013;191(1):27\u201334.","journal-title":"Lung"},{"issue":"2","key":"8568_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/sji.12567","volume":"86","author":"P Mendez-Samperio","year":"2017","unstructured":"Mendez-Samperio P. Diagnosis of tuberculosis in HIV co-infected individuals: current status, Challenges and Opportunities for the future. Scand J Immunol. 2017;86(2):76\u201382.","journal-title":"Scand J Immunol"},{"issue":"3","key":"8568_CR17","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S1473-3099(18)30537-1","volume":"19","author":"PY Khan","year":"2019","unstructured":"Khan PY, Yates TA, Osman M, Warren RM, van der Heijden Y, Padayatchi N, et al. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2019;19(3):e77\u2013e88.","journal-title":"Lancet Infect Dis"},{"key":"8568_CR18","doi-asserted-by":"crossref","unstructured":"Scully EP, Bryson BD. Unlocking the complexity of HIV and Mycobacterium tuberculosis coinfection. J Clin Invest. 2021;131(22).","DOI":"10.1172\/JCI154407"},{"issue":"11","key":"8568_CR19","first-page":"967","volume":"49","author":"GGY Zhang","year":"2015","unstructured":"Zhang GGY, Wang Q, Zhang S, Liao Q, Yu G, Wang K, Wang J, Ye S, Liu Z. Survival time and associated factors of 8 310 AIDS patients initially receiving antiretroviral treatment of Liangshan Yi Autonomous Prefecture, Sichuan province of China. Zhonghua Yu Fang Yi Xue Za Zhi. 2015;49(11):967\u201372.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"8568_CR20","unstructured":"Brett KD, Severn C. M. Identification of Tuberculosis: A Review of the Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. 2020;2020."},{"issue":"1","key":"8568_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmi.2014.08.008","volume":"21","author":"JY Chien","year":"2015","unstructured":"Chien JY, Chen YT, Wu SG, Lee JJ, Wang JY, Yu CJ. Treatment outcome of patients with isoniazid mono-resistant tuberculosis. Clin Microbiol Infect. 2015;21(1):59\u201368.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"8568_CR22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/resp.13304","volume":"23","author":"C Lange","year":"2018","unstructured":"Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology. 2018;23(7):656\u201373.","journal-title":"Respirology"},{"issue":"7","key":"8568_CR23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","volume":"90","author":"L Nguyen","year":"2016","unstructured":"Nguyen L. Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch Toxicol. 2016;90(7):1585\u2013604.","journal-title":"Arch Toxicol"},{"key":"8568_CR24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","volume":"8","author":"HMA Hameed","year":"2018","unstructured":"Hameed HMA, Islam MM, Chhotaray C, Wang C, Liu Y, Tan Y, et al. Molecular targets related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains. Front Cell Infect Microbiol. 2018;8:114.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"8568_CR25","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/jam.14478","volume":"128","author":"R Singh","year":"2020","unstructured":"Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547\u201367.","journal-title":"J Appl Microbiol"},{"key":"8568_CR26","unstructured":"Chinese Society of Nutrition: Dietary Guidelines for Chinese residents. (2022), 1 edition. Bei Jing: People\u2019s Medical Publishing House; 2022."},{"issue":"3","key":"8568_CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3201\/eid2503.180572","volume":"25","author":"Y Pang","year":"2019","unstructured":"Pang Y, An J, Shu W, Huo F, Chu N, Gao M, et al. Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008\u20132017. Emerg Infect Dis. 2019;25(3):457\u201364.","journal-title":"Emerg Infect Dis"},{"key":"8568_CR28","first-page":"1","volume":"854","author":"Physical status","year":"1995","unstructured":"Physical status. The use of and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854:1\u2013452.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"8568_CR29","unstructured":"World Health Organization (2016) Systematic screening for active tuberculosis: principles and recommendations. http:\/\/www.who.int\/tb\/tbscreening\/en\/. Accessed August 18, 2016."},{"issue":"Suppl 1","key":"8568_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/344657","volume":"36","author":"JBC Nachega","year":"2003","unstructured":"Nachega JBC. Tuberculosis drug resistance: A global threat. Clin Infect Dis. 2003;36(Suppl 1):24\u201330.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8568_CR31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12916-020-01849-7","volume":"18","author":"JR Winter","year":"2020","unstructured":"Winter JR, Smith CJ, Davidson JA, Lalor MK, Delpech V, Abubakar I, et al. The impact of HIV infection on tuberculosis transmission in a country with low tuberculosis incidence: a national retrospective study using molecular epidemiology. BMC Med. 2020;18(1):385.","journal-title":"BMC Med"},{"issue":"4","key":"8568_CR32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10096-020-04077-2","volume":"40","author":"W Kang","year":"2021","unstructured":"Kang W, Du J, Yang S, Yu J, Chen H, Liu J, et al. The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study. Eur J Clin Microbiol Infect Dis. 2021;40(4):787\u2013800.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"8568_CR33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12879-022-07072-4","volume":"22","author":"B Gilmour","year":"2022","unstructured":"Gilmour B, Xu Z, Bai L, Alene KA, Clements ACA. The impact of ethnic minority status on tuberculosis diagnosis and treatment delays in Hunan Province, China. BMC Infect Dis. 2022;22(1):90.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"8568_CR34","doi-asserted-by":"crossref","first-page":"e89723","DOI":"10.1371\/journal.pone.0089723","volume":"9","author":"J Xu","year":"2014","unstructured":"Xu J, Tang W, Cheng S, Mahapatra T, Zhou L, Lai Y, et al. Prevalence and predictors of HIV among chinese tuberculosis patients by provider-initiated HIV testing and counselling (PITC): a multisite study in South Central of China. PLoS ONE. 2014;9(2):e89723.","journal-title":"PLoS ONE"},{"issue":"1","key":"8568_CR35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12879-019-4262-2","volume":"19","author":"T Li","year":"2019","unstructured":"Li T, Cheng Q, Li C, Stokes E, Collender P, Ohringer A, et al. Evidence for heterogeneity in China\u2019s progress against pulmonary tuberculosis: uneven reductions in a major center of ongoing transmission, 2005\u20132017. BMC Infect Dis. 2019;19(1):615.","journal-title":"BMC Infect Dis"},{"key":"8568_CR36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.puhe.2020.06.054","volume":"186","author":"A Badawi","year":"2020","unstructured":"Badawi A, Gregg B, Vasileva D. Systematic analysis for the relationship between obesity and tuberculosis. Public Health. 2020;186:246\u201356.","journal-title":"Public Health"},{"issue":"4","key":"8568_CR37","doi-asserted-by":"crossref","first-page":"e0175183","DOI":"10.1371\/journal.pone.0175183","volume":"12","author":"H Zhang","year":"2017","unstructured":"Zhang H, Xin H, Li X, Li H, Li M, Lu W, et al. A dose-response relationship of smoking with tuberculosis infection: a cross-sectional study among 21008 rural residents in China. PLoS ONE. 2017;12(4):e0175183.","journal-title":"PLoS ONE"},{"issue":"22","key":"8568_CR38","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1001\/jama.283.22.2968","volume":"283","author":"DP Chin","year":"2000","unstructured":"Chin DP, Crane CM, Diul MY, Sun SJ, Agraz R, Taylor S, et al. Spread of Mycobacterium tuberculosis in a community implementing recommended elements of Tuberculosis Control. JAMA. 2000;283(22):2968\u201374.","journal-title":"JAMA"},{"issue":"7","key":"8568_CR39","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S2352-3018(19)30154-7","volume":"6","author":"G Meintjes","year":"2019","unstructured":"Meintjes G, Brust JCM, Nuttall J, Maartens G. Management of active tuberculosis in adults with HIV. The Lancet HIV. 2019;6(7):e463\u2013e74.","journal-title":"The Lancet HIV"},{"issue":"11","key":"8568_CR40","first-page":"1518","volume":"38","author":"TYC Li","year":"2017","unstructured":"Li TYC, He JG, Li YK, Xiao Y, Li J, Wang DX, Chen C, Wu JL. Spatial-temporal distribution of smear positive pulmonary tuberculosis in Liangshan Yi autonomous prefecture, Sichuan province, 2011\u20132016. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(11):1518\u201322.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"11","key":"8568_CR41","first-page":"1518","volume":"38","author":"T Li","year":"2017","unstructured":"Li T, Yang CH, He JG, Li YK, Xiao Y, Li J, et al. Spatial-temporal distribution of smear positive pulmonary tuberculosis in Liangshan Yi autonomous prefecture, Sichuan province, 2011\u20132016. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(11):1518\u201322.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"8568_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1746-4269-5-13","volume":"5","author":"C Long","year":"2009","unstructured":"Long C, Li S, Long B, Shi Y, Liu B. Medicinal plants used by the Yi ethnic group: a case study in central Yunnan. J Ethnobiol Ethnomed. 2009;5:13.","journal-title":"J Ethnobiol Ethnomed"},{"issue":"2","key":"8568_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/s1806-37562017000000443","volume":"44","author":"DR Silva","year":"2018","unstructured":"Silva DR, Munoz-Torrico M, Duarte R, Galvao T, Bonini EH, Arbex FF, et al. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018;44(2):145\u201352.","journal-title":"J Bras Pneumol"},{"issue":"3","key":"8568_CR44","doi-asserted-by":"crossref","first-page":"e0172942","DOI":"10.1371\/journal.pone.0172942","volume":"12","author":"S Hermosilla","year":"2017","unstructured":"Hermosilla S, You P, Aifah A, Abildayev T, Akilzhanova A, Kozhamkulov U, et al. Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan. PLoS ONE. 2017;12(3):e0172942.","journal-title":"PLoS ONE"},{"issue":"5","key":"8568_CR45","doi-asserted-by":"crossref","first-page":"e10736","DOI":"10.1371\/journal.pone.0010736","volume":"5","author":"L Gao","year":"2010","unstructured":"Gao L, Zhou F, Li X, Jin Q. HIV\/TB co-infection in mainland China: a meta-analysis. PLoS ONE. 2010;5(5):e10736.","journal-title":"PLoS ONE"},{"key":"8568_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijid.2021.11.019","volume":"115","author":"W Kang","year":"2022","unstructured":"Kang W, Liu S, Du J, Tang P, Chen H, Liu J, et al. Epidemiology of concurrent extrapulmonary tuberculosis in inpatients with extrapulmonary tuberculosis lesions in China: a large-scale observational multi-centre investigation. Int J Infect Dis. 2022;115:79\u201385.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"8568_CR47","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1148\/rg.2019190109","volume":"39","author":"SY Rodriguez-Takeuchi","year":"2019","unstructured":"Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary Tuberculosis: pathophysiology and imaging findings. Radiographics. 2019;39(7):2023\u201337.","journal-title":"Radiographics"},{"issue":"1","key":"8568_CR48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/cid\/cis303","volume":"55","author":"IL Leeds","year":"2012","unstructured":"Leeds IL, Magee MJ, Kurbatova EV, del Rio C, Blumberg HM, Leonard MK, et al. Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis. 2012;55(1):75\u201381.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"8568_CR49","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrurol.2011.172","volume":"8","author":"A Abbara","year":"2011","unstructured":"Abbara A, Davidson RN. Medscape. Etiology and management of genitourinary tuberculosis. Nat Rev Urol. 2011;8(12):678\u201388.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"8568_CR50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.gtc.2021.02.004","volume":"50","author":"H Eraksoy","year":"2021","unstructured":"Eraksoy H. Gastrointestinal and abdominal tuberculosis. Gastroenterol Clin North Am. 2021;50(2):341\u201360.","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"8568_CR51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/sur.2020.106","volume":"22","author":"TG Wolde","year":"2021","unstructured":"Wolde TG, Huang S, Zhang K, Wu J, Gao W, Li Q, et al. Evaluation of twenty-one cases of abdominal tuberculosis: a single-center experience. Surg Infect (Larchmt). 2021;22(3):299\u2013304.","journal-title":"Surg Infect (Larchmt)"},{"issue":"6","key":"8568_CR52","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.crad.2011.11.003","volume":"67","author":"WK Lee","year":"2012","unstructured":"Lee WK, Van Tonder F, Tartaglia CJ, Dagia C, Cazzato RL, Duddalwar VA, et al. CT appearances of abdominal tuberculosis. Clin Radiol. 2012;67(6):596\u2013604.","journal-title":"Clin Radiol"},{"issue":"2","key":"8568_CR53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/s0004-2803.201900000-35","volume":"56","author":"S Udgirkar","year":"2019","unstructured":"Udgirkar S, Jain S, Pawar S, Chandnani S, Contractor Q, Rathi P. Clinical Profile, Drug Resistance Pattern and Treatment Outcomes of Abdominal Tuberculosis Patients in western India. Arq Gastroenterol. 2019;56(2):178\u201383.","journal-title":"Arq Gastroenterol"},{"issue":"8","key":"8568_CR54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrgastro.2011.115","volume":"8","author":"MA Almadi","year":"2011","unstructured":"Almadi MA, Aljebreen AM, Sanai FM, Marcus V, Almeghaiseeb ES, Ghosh S. New insights into gastrointestinal and hepatic granulomatous disorders. Nat Rev Gastroenterol Hepatol. 2011;8(8):455\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8568_CR55","doi-asserted-by":"crossref","unstructured":"Mirzayev F, Viney K, Linh NN, Gonzalez-Angulo L, Gegia M, Jaramillo E et al. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J. 2021;57(6).","DOI":"10.1183\/13993003.03300-2020"},{"key":"8568_CR56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40249-016-0103-3","volume":"5","author":"Q Long","year":"2016","unstructured":"Long Q, Qu Y, Lucas H. Drug-resistant tuberculosis control in China: progress and challenges. Infect Dis Poverty. 2016;5:9.","journal-title":"Infect Dis Poverty"},{"key":"8568_CR57","unstructured":"Y M. Progress and application of molecular genetics in the research of Mycobacterium tuberculosis. Kekkaku. 1993;68(11):709\u201314."},{"issue":"12","key":"8568_CR58","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3349\/ymj.2020.61.12.1034","volume":"61","author":"SH Kwak","year":"2020","unstructured":"Kwak SH, Choi JS, Lee EH, Lee SH, Leem AY, Lee SH, et al. Characteristics and treatment outcomes of Isoniazid Mono-Resistant tuberculosis: a retrospective study. Yonsei Med J. 2020;61(12):1034\u201341.","journal-title":"Yonsei Med J"},{"issue":"9","key":"8568_CR59","doi-asserted-by":"crossref","first-page":"e04945","DOI":"10.1016\/j.heliyon.2020.e04945","volume":"6","author":"Z Qi","year":"2020","unstructured":"Qi Z, Gao X, Wang YF, Liu C. Epidemic characteristics and drug resistance of tuberculosis in North China. Heliyon. 2020;6(9):e04945.","journal-title":"Heliyon"},{"key":"8568_CR60","unstructured":"World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. WHO Press; 2013."},{"key":"8568_CR61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tube.2017.01.002","volume":"103","author":"F Di Gennaro","year":"2017","unstructured":"Di Gennaro F, Pizzol D, Cebola B, Stubbs B, Monno L, Saracino A, et al. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: a review. Tuberculosis (Edinb). 2017;103:44\u201351.","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"8568_CR62","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1017\/S0950268804002869","volume":"132","author":"SJ Conaty","year":"2004","unstructured":"Conaty SJ, Hayward AC, Story A, Glynn JR, Drobniewski FA, Watson JM. Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance. Epidemiol Infect. 2004;132(6):1099\u2013108.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"8568_CR63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/649022","volume":"31","author":"DJ Horne","year":"2010","unstructured":"Horne DJ, Johnson CO, Oren E, Spitters C, Narita M. How soon should patients with smear-positive tuberculosis be released from inpatient isolation? Infect Control Hosp Epidemiol. 2010;31(1):78\u201384.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"8568_CR64","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3855\/jidc.6162","volume":"9","author":"OS Elmi","year":"2015","unstructured":"Elmi OS, Hasan H, Abdullah S, Mat Jeab MZ, Bin Alwi Z, Naing NN. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. J Infect Dev Ctries. 2015;9(10):1076\u201385.","journal-title":"J Infect Dev Ctries"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08568-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08568-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T20:07:14Z","timestamp":1700251634000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08568-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8568"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08568-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3007578\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All clinical data and laboratory results, as well as the waiver of patient informed consent has been approved by the Ethics Review Committee of Sichuan Provincial Academy of Medical Sciences and Sichuan Provincial People\u2019s Hospital (Protocol 20220-254).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"586"}}